Drug
Tocilizumab Methotrexate
Tocilizumab Methotrexate: highest development phase Phase 3, developed by Chugai. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Chugai
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tocilizumab + methotrexate(MTX) NCT01258712 | Phase 3 | Rheumatoid Arthritis (RA) |
Latest
No recent events.
Follow Tocilizumab Methotrexate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.